European Archives - Page 53 of 1422 - European Medical Journal

Acute Pancreatitis Warnings Strengthened on GLP-1RAs

The UK’s MHRA has strengthened warnings of acute pancreatitis on GLP-1RAs, following rare reports of necrotising and fatal pancreatitis.

childhood allergy

Advanced Maternal Age and Childhood Allergy Risk

Children born to older mothers showed lower risks of food allergy, wheezing, and allergen sensitisation in early childhood, suggesting advanced maternal age may have a protective role.

Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk

Low Midlife PSA Linked to Reduced 20-Year Prostate Cancer Risk

A 20-year cohort study shows men with low baseline PSA face minimal prostate cancer risk, supporting personalised screening strategies using PSA and PSA density.

Psychosocial Stress Raises Risk of Dementia and Stroke

Psychosocial Stress Raises Risk of Dementia and Stroke

Cumulative psychosocial stress across childhood and adulthood is linked to higher dementia and stroke risk, partly driven by depression.

bone loss

EAHAD 2026: Bone Loss Risk Reduced by Early Haemophilia Prophylaxis

Early initiation of prophylaxis before 20 years of age protects against bone loss in haemophilia, while delayed or absent treatment is linked to significantly higher osteoporosis risk.

septic shock

Key Predictors of Death in Septic Shock Identified

A large meta-analysis identifies patient, clinical, and biochemical factors linked to early mortality in septic shock, helping clinicians stratify risk.

Sleep Quality Linked to Favourable ART Outcomes

Sleep Quality Linked to Favourable ART Outcomes

Good sleep quality is significantly associated with better ART pregnancy and implantation rates, a 2026 meta-analysis has found.

Fitness Test Predicts Pulmonary Hypertension Outcomes - EMJ

Simple Fitness Test Predicts Pulmonary Hypertension Outcomes

Performance on the one-minute sit-to-stand test was a strong predictor of prognosis. Each additional repetition was associated with a lower risk of adverse outcomes (hazard ratio: 0.94; 95% CI: 0.90–0.98; p

gene therapy

EAHAD 2026: Nine-Year Outcomes of Gene Therapy

Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.

Vaccines on green background

Scalable chikungunya vaccine breakthrough

Researchers at Griffith University’s are on the cusp of a significant breakthrough in the development of a vaccine for the chikungunya virus.